SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000008
Filing Date
2007-02-12
Accepted
2007-02-09 17:49:37
Documents
4
Period of Report
2007-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR PIPE FEB. 2007 pipefeb2007.htm 8-K 31066
2 DOR SECURITIES PURCHASE AGREEMENT PIPE 2007 securitiespurchaseagreement.htm EX-10.1 315923
3 REGISTRATION RIGHTS AGREEMENT regrights.htm EX-10.2 215092
4 PRESS RELEASE pressrelease.htm EX-99.1 23628
  Complete submission text file 0000812796-07-000008.txt   587494
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 07599756
SIC: 2834 Pharmaceutical Preparations